Silver Book Fact

Using technologies as treatment for heart disease helps generate cost savings, including a total of $1930 annual savings per person, and a $1.5 billion increased tax revenue

Chatterjee A, King J, Kubendran S, DeVol R. Healthy Savings: Medical Technology and the Economic Burden of Disease. Santa Monica, CA: Milken Institute; 2014:15. http://lifechanginginnovation.org/sites/default/files/files/HealthySavingsFinal(1).pdf. Accessed November 3, 2015

Reference

Title
Healthy Savings: Medical Technology and the Economic Burden of Disease
Publisher
Milken Institute
Publication Date
2014
Authors
Chatterjee A, King J, Kubendran S, DeVol R
Pages
15
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • From 1970-2000, gains in longevity were greatest for people between the ages of 40 and 60, and greater for men than women, in large part because of advances in the…  
  • Cost of warfarin therapy for AFib patients
    In patients with nonvalvular atrial fibrillation (AF) and one additional stroke risk factor, warfarin therapy cost $8,000 per quality-adjusted life-year (QALY) saved.  
  • Glycoprotein inhibitors have been shown to reduce the risk of death, a second heart attack, or the need for revascularization by 48% to 52% in patients who have suffered a…  
  • Satisfaction rates of heart valve disease patients with their treatment
     
  • Effectiveness of treating ischemic stroke victims with rt-PA within 3 hours of symptom onset
    A study of the effectiveness of treating ischemic stroke victims with rt-PA within 3 hours of symptom onset found an estimated impact on long-term health outcomes of 564 quality-adjusted life-years saved…